Expert Cancer Panel: Invasive high-grade breast carcinoma (ER-/PR+/HER2-) w/ PET-avid scapula lesion

Expert Cancer Panel: Metastatic ER+, PR/HER2- breast cancer w/ brain and leptomeningeal metsПодробнее

Expert Cancer Panel: Grade 2 invasive lobular breast carcinoma (ER positive/PR negative/HER2 3+)Подробнее

Expert Cancer Panel: ER/PR positive, HER2 negative breast cancer and concerning liver lesionПодробнее

Expert Cancer Panel: Stage IIB IDC (ER+/PR+/HER2-/BRCA+) w/ MammaPrint showing high recurrence riskПодробнее

Expert Cancer Panel: DCIS and stage IA HER2+ IDC with close anterior margin after lumpectomyПодробнее

Expert Cancer Panel: History of DCIS now w/ IDC (ER+/PR+/HER2-) w/ 1 involved axillary lymph nodeПодробнее

Expert Cancer Panel: Multicentric, clinical N1, IDC (ER+/PR+/HER2-/G3) s/p NAC, mastectomy, and SLNBПодробнее

Expert Cancer Panel: ER/PR+, HER2- breast cancer and liver lesions too small to characterizeПодробнее

HER2/neu Positive or HER2/neu enriched Cancer | A Type of breast cancer | Dr Jay R. AnamПодробнее

Expert Cancer Panel: Stage II ER+/PR poor/HER2+ right breast IDC with pCR after neoadjuvant therapyПодробнее

Expert Cancer Panel: Stage I ER+/PR+/HER2- right breast IDC considering breast conservation surgeryПодробнее

Expert Cancer Panel: Locally recurrent ER/PR positive, HER2 negative breast cancerПодробнее

Expert Cancer Panel: Metastatic breast cancer to the brainПодробнее

Expert Cancer Panel: Stage IV HER2+ IDC w/ fungating breast mass, lung mets, L5/femoral fracturesПодробнее

Expert Cancer Panel: Node positive, Grade 3 IDC, ER/PR-, HER2+ and 13 weeks pregnantПодробнее

Expert Cancer Panel: HER2+ IDC s/p lumpectomy/adjuvant therapy w/ recurrent HER2+ mucinous IDCПодробнее

The Role of ER, PR, and HER2/Neu Receptors in Breast Cancer Treatment: Insights with Dr. Neha GuptaПодробнее

Get to know HER2-positive breast cancer and its targeted treatmentsПодробнее

Expert Cancer Panel: Node negative, ER/PR+, HER2- breast cancer and family history of breast cancerПодробнее